Veeva

Veeva Systems - Cloud-based Software for the Global Life Sciences Industry

Veeva is a leading global provider of industry-specific, cloud-based software solutions for the life sciences industry. Our solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance.

Latest News

February 6, 2018 Veeva to Release Fiscal 2018 Fourth Quarter and Full Year Results on February 27, 2018
Veeva Systems Inc. (NYSE: VEEV), a leading industry cloud provider for life sciences, will announce financial results for its fiscal fourth quarter and full fiscal year which ended January 31, 2018 after market close on February 27, 2018 . Veeva will host a conference call and webcast that day at 1:30 p.m. PT ( 4:30 p.m. ET ) to discuss its financial results. Event: Veeva’s Fiscal 2018 Fourth Quarter and Full Year Results Conference Call Date: Tuesday, February 27, 2018 Time: 1:30 p.m. PT (4:30 p.m. ET) Live Dial-In: 1-833-235-5654, Domestic 1-647-689-4160, International Conference ID 839 8886 Webcast: ir.veeva.com   A webcast replay will be available on Veeva’s investor relations website following the call. About Veeva Systems Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 600 customers, ranging from the world's largest pharmaceutical companies to...
December 5, 2017 Veeva Announces Fiscal 2018 Third Quarter Results
Total Revenues of $176.1M, up 23% Year-Over-Year Subscription Services Revenues of $141.9M, up 25% Year-Over-Year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal third quarter ended October 31, 2017. “Veeva delivered another strong quarter with results above our guidance,” said CEO Peter Gassner . “We executed well across all product areas and geographies and went the extra mile for customer success. We also announced a new product line, Veeva Vault Safety, to help our customers become more efficient, effective and compliant when managing drug safety." Fiscal 2018 Third Quarter Results: Revenues : Total revenues for the third quarter were $176.1 million , up from $142 .8 million one year ago, an increase of 23% year-over-year. Subscription services revenues for the third quarter were $141.9 million , up from $113.6 million one year ago, an increase of 25% year-over-year....
September 21, 2017 Industry Survey Reveals Clinical Data Management Delays Are Slowing Trial Completion
83% of life sciences organizations release the clinical database after first patient, first visit, which is associated with downstream delays of up to a month in key data management activities One of the largest, most in-depth surveys of clinical data management professionals shows that the time it takes companies to design and release clinical study databases is having a negative impact on conducting and completing trials. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170921005426/en/ (Graphic: Business Wire) According to the 2017 eClinical Landscape Study from Tufts Center for the Study of Drug Development , it takes companies an average of 68 days to build and release a clinical study database. Delays in releasing the study database are associated with an increase of nearly a month downstream for other data management processes such as patient data entry and time to lock the database at the end of the study....

Investor Contact

Rick Lund
Investor Relations Director
Email: ir@veeva.com
Phone: 1 (925) 271-9816

Email Alerts

Email *
Mailing Lists *



 
Enter the code shown above.